Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000088

President and CEO returned 521,125 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Brunn Carsten · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-13 Returned to the company : show line 1 in the form −55,000 $2.06 $113,300 728,081 D
2023-11-13 Returned to the company : show line 2 in the form −13,600 $2.06 $28,016 714,481 D
2023-11-13 Returned to the company : show line 3 in the form −169,725 $2.06 $349,634 544,756 D
2023-11-13 Returned to the company : show line 4 in the form −282,800 $2.06 $582,568 261,956 D

Table II: Derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-13 Returned to the company : show line 5 in the form Employee Stock Option (right to buy) −1,000,000 0 D
2023-11-13 Returned to the company : show line 6 in the form Employee Stock Option (right to buy) −330,000 0 D
2023-11-13 Returned to the company : show line 7 in the form Employee Stock Option (right to buy) −400,000 $0.31 $124,000 0 D
2023-11-13 Returned to the company : show line 8 in the form Employee Stock Option (right to buy) −600,000 0 D
2023-11-13 Returned to the company : show line 9 in the form Employee Stock Option (right to buy) −75,000 0 D
2023-11-13 Returned to the company : show line 10 in the form Employee Stock Option (right to buy) −670,000 0 D
2023-11-13 Returned to the company : show line 11 in the form Employee Stock Option (right to buy) −163,000 0 D
2023-11-13 Returned to the company : show line 12 in the form Employee Stock Option (right to buy) −1,056,100 0 D
2023-11-13 Returned to the company : show line 13 in the form Employee Stock Option (right to buy) −1,275,000 $0.93 $1,185,750 0 D
Loading xslF345X05/wk-form4_1700087164.xml…